State Street’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

State Street’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,648,579	Closed	-$49.4M	–	5018
2022 Q1	$49.4M	Sell	2,648,579 -54	-0%	-$972	﹤0.01%	1773
2021 Q4	$56.7M	Buy	2,648,633 +248,056	+10%	+$4.89M	﹤0.01%	1723
2021 Q3	$44.4M	Buy	2,400,577 +293,821	+14%	+$5.92M	﹤0.01%	1892
2021 Q2	$45.1M	Buy	2,106,756 +856,287	+68%	+$17.4M	﹤0.01%	1922
2021 Q1	$24.1M	Buy	+1,250,469	New	+$22M	﹤0.01%	2247

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

State Street's OCDX Position: Q2 2022 in Review

State Street sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 2,648,579 shares — an estimated $49.4M sold.

State Street first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $56.7M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

State Street reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
State Street sold 2,648,579 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $49.4M.
State Street first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
State Street's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $56.7M in Q4 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on State Street's 13F filing for Q2 2022, filed 15 Aug 2022.